Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327 (19 July), doi:10.1136/bmj.327.7407.0-b
Non-steroidal anti-inflammatory drugs may prevent the development of Alzheimer's disease, though aspirin has only a modest preventive effect. In a meta-analysis, Etminan and colleagues (p 128) analysed data from nine observational studies with almost 15 000 participants who had used NSAIDs. The risk of developing Alzheimer's disease was reduced by about 30%. The benefit with aspirin was 13%. In addition, long term users of NSAIDs had a greater benefit than intermediate term users. The appropriate dose, duration, and ratios of risk to benefit are still unclear. The authors say that routine use of NSAIDs is not recommended until results from ongoing randomised controlled trials become available.
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?